TAPUR Study Launches to Evaluate Off-Label Uses of Targeted Cancer Therapies

TAPUR Study Launches to Evaluate Off-Label Uses of Targeted Cancer Therapies

From - Diagnostic Testing & Emerging Technologies
The Targeted Agent and Profiling Utilization Registry (TAPUR) study began recruiting its first patients last month. The trial, the first clinical trial undertaken by …


. . . read more

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here